Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections

Published:2012-03-04 Issue:7 Volume:44 Page:548-550
ISSN:0036-5548
Container-title:Scandinavian Journal of Infectious Diseases
language:en
Short-container-title:Scandinavian Journal of Infectious Diseases

Author:

Hoyo Irma,Martínez-Pastor Juan,Garcia-Ramiro Sebastian,Climent Consuelo,Brunet Mercé,Cuesta Marta,Mensa Josep,Soriano Alex

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),General Immunology and Microbiology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00365548.2012.663931

Reference5 articles.

1. Linezolid and rifampin: Drug interaction contrary to expectations?

2. Unexpected Effect of Rifampin on the Pharmacokinetics of Linezolid: In Silico and In Vitro Approaches to Explain Its Mechanism

3. Comparative Study of the Effects of Pyridoxine, Rifampin, and Renal Function on Hematological Adverse Events Induced by Linezolid

4. Decreased Serum Linezolid Levels in a Critically Ill Patient Receiving Concomitant Linezolid and Rifampin

5. Persistent MRSA Bacteremia in a Patient with Low Linezolid Levels

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review;European Journal of Clinical Pharmacology;2024-02-29

2. Controversies in the microbiological diagnosis and treatment of bone and joint infections;Orthopaedics and Trauma;2023-12

3. Evaluation of the impact of rifampicin on the plasma concentration of linezolid in tuberculosis co-infected patients;Frontiers in Pharmacology;2023-11-07

4. Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?;Expert Review of Anti-infective Therapy;2023-05-08

5. Linezolid Population Pharmacokinetics to Improve Dosing in Cardiosurgical Patients: Factoring a New Drug–Drug Interaction Pathway;Clinical Infectious Diseases;2022-11-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3